Vietnam Health Insurance "Ineffective"
Many Vietnamese public-sector workers who pay for health insurancehesitate to use their insurance cards when seeking treatment, reports the Vietnam Courier. This is because they often wait several hours to see a doctor and then receive inadequate prescriptions, and have to pay hidden charges if they spend any time in hospital.
Most of the insured now choose to pay the same rate for treatment as the uninsured. As a result, under 10% of people buy health insurance, although coverage is expected to reach 10 million by year-end, from 3.8 million in 1993.
Vietnam now spends one-sixth of its annual state budget, of 500 billion dong ($45.5 million) on free health care for the poor, the elderly and war invalids.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze